Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial
Gullaksen S, Vernstrøm L, Sørensen SS, et al.
Diabetologia. Pub. online 6 Feb 2023.
Leggi
Gullaksen S, Vernstrøm L, Sørensen SS, et al.
Diabetologia. Pub. online 6 Feb 2023.
Leggi
Burnside M, Lewis D, Crocket H, et al.
Diabetes Technol Ther. Pub. online 10 Feb 2023.
Leggi
Marzinotto I, Pittman DL, Williams AJK, et al.
Diabetologia. Pub. online 10 Feb 2023.
Leggi
Fisher SA, Stetson BT, Kominiarek MA
JAMA. Pub. online 10 Feb 2023.
Leggi
Nauck MA, Mirna AEA, Quast DR
Diabetes Obes Metab. Pub. online 26 Jan 2023.
Leggi
Heller S, Battelino T, Bailey TS, et al.
Diabetes Obes Metab.Pub. online 24 Jan 2023.
Leggi
Maturi RK, Glassman AR, Josic K, et al.
JAMA. 2023;329(5):376-385.
Leggi
Igudesman D, Crandell J, Corbin KD, et al.
Nutr Metab Cardiovasc Dis. 2023;33(2):388-398.
Leggi
Poli A, Catapano AL, Corsini A, et al.
Nutr Metab Cardiovasc Dis. 2023;33(2):245-257.
Leggi
Chen Y, Chen Z, Pan L, et al.
JAMA Intern Med. Pub. online 30 Jan 2023.
Leggi